![Alexander Casdin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexander Casdin
Direktor/Vorstandsmitglied bei
ERASCA, INC.
Vermögen: 9 Mio $ am 31.05.2026
Profil
Alexander Whitman Casdin is the founder of Casdin Advisors LLC.
Current jobs include Chief Executive Officer at Epirium Bio, Inc. starting in 2025, Treasurer & Director at Conquer Cancer Foundation of the American Society of Clinical since 2015, Independent Director at Erasca, Inc. since 2018, and Member of the Presidents Leadership Council at Brown University.
Former jobs include Chief Executive Officer at Reneo Capital Management LP from 2013 to 2020, Independent Director at DUSA Pharmaceuticals, Inc. from 2009 to 2012, Director at DiaVacs, Inc., Independent Director at Ignyta, Inc. from 2013 to 2018, Independent Director at Project Sage Oldco, Inc. from 2023 to 2024, Vice President-Finance at Amylin Pharmaceuticals, Inc. from 2009 to 2011, Portfolio Manager at Pequot Capital Management, Inc. in 2001, Managing Partner at Cooper Hill Partners LLC from 2001 to 2005, Chief Financial Officer at Sophiris Bio, Inc. from 2011 to 2012, Member of the Artists Council at Whitney Museum of American Art, and Advisor at Mountain Group Partners LLC.
Education includes undergraduate degree from Brown University and MBAistration from Columbia Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ERASCA, INC. 0,21 % | 15.04.2026 | 667 724 ( 0,21 % ) | 9 Mio $ | 31.05.2026 |
Aktive Positionen von Alexander Casdin
| Unternehmen | Position | Beginn |
|---|---|---|
| ERASCA, INC. | Direktor/Vorstandsmitglied | 02.07.2018 |
Epirium Bio, Inc.
 Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Vorstandsvorsitzender | 01.01.2025 |
Conquer Cancer Foundation of the American Society of Clinical
 Conquer Cancer Foundation of the American Society of Clinical Miscellaneous Commercial ServicesCommercial Services Improves cancer care and prevention | Direktor/Vorstandsmitglied | 01.12.2015 |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Alexander Casdin
| Unternehmen | Position | Ende |
|---|---|---|
| PROJECT SAGE OLDCO, INC. | Direktor/Vorstandsmitglied | 28.06.2024 |
Reneo Capital Management LP
 Reneo Capital Management LP Investment ManagersFinance Provides investment advice | Vorstandsvorsitzender | 01.10.2020 |
| IGNYTA INC | Direktor/Vorstandsmitglied | 07.02.2018 |
DUSA Pharmaceuticals, Inc.
 DUSA Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets photodynamic therapies & dermatological pharmaceutical products | Direktor/Vorstandsmitglied | 01.12.2012 |
| SOPHIRIS BIO | Finanzdirektor/CFO | 14.09.2012 |
Ausbildung von Alexander Casdin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
69
Beziehungen ersten Grades
17
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 17 |
|---|---|
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
DUSA Pharmaceuticals, Inc.
DUSA Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets photodynamic therapies & dermatological pharmaceutical products | Health Technology |
Pequot Capital Management, Inc.
 Pequot Capital Management, Inc. Investment ManagersFinance Pequot Capital Management's investment philosophy is based on deep fundamental research and unbiased thematic analysis to identify and capitalize on market inefficiencies across an industry sector or a company's lifecycle. The firm invests in public equities, private equity, venture capital, distressed securities and a variety of fixed-income securities. Pequot Capital Management tends to invest in the stocks of US small-cap companies in the consumer services, health technology and commercial services sectors. They maintain a very high turnover rate. | Finance |
Cooper Hill Partners LLC (Investment Management)
 Cooper Hill Partners LLC (Investment Management) Investment ManagersFinance Copper is a longer-term, high portfolio turnover shop with a focus on value. They invest long/short in the biotechnology sector. | Finance |
Sophiris Bio, Inc.
 Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of urological diseases | Health Technology |
Epirium Bio, Inc.
Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Health Technology |
DiaVacs, Inc.
 DiaVacs, Inc. BiotechnologyHealth Technology Develops and commercializes cell-based therapys for treatment of type 1 diabetes | Health Technology |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Whitney Museum of American Art
 Whitney Museum of American Art Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Mountain Group Partners LLC
 Mountain Group Partners LLC Investment ManagersFinance Mountain Group Partners invests in companies located in the United States. The firm targets companies operating in the fields of life sciences, healthcare and disruptive technology. It provides financing for early-stage capital requirements. | Finance |
Project Sage Oldco, Inc.
 Project Sage Oldco, Inc. Medical SpecialtiesHealth Technology Develops and sells medical aesthetics products | Health Technology |
Conquer Cancer Foundation of the American Society of Clinical
Conquer Cancer Foundation of the American Society of Clinical Miscellaneous Commercial ServicesCommercial Services Improves cancer care and prevention | Commercial Services |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reneo Capital Management LP
Reneo Capital Management LP Investment ManagersFinance Provides investment advice | Finance |
Erasca, Inc.
 Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers | Health Technology |
Casdin Advisors LLC |
